ETFMG Treatments Testing and Advancements ETF - USD Stock price

ETF

GERM

US26924G7631

Market Closed - Nyse 04:10:00 2024-03-18 pm EDT 5-day change 1st Jan Change
18.06 USD -0.55% Intraday chart for ETFMG Treatments Testing and Advancements ETF - USD -2.82% 0.00%
Dynamic Chart

Investment objective

The Fund's investment objective seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Prime Treatments, Testing and Advancements Index.
Name
Price
Change
5d. change
1-year change
Weight
- RUB 0.00% - - -.--%
0.214 EUR -.--% - - -.--%
- EUR -.--% - - -.--%
- GBX -.--% - - -.--%
- AUD -.--% - - -.--%
- USD -.--% - - -.--%
- AUD -.--% - - -.--%
- EUR -.--% - - -.--%
- NOK -.--% - - -.--%
0.3938 CAD -17.11% - - -.--%
21.1 CAD -0.24% - - -.--%
104.3 USD +0.39%-6.89%-30.50%6.69%
147.4 USD -1.25%-1.13%-20.51%6.12%
209.5 USD +0.16%-4.11%-1.77%5.51%
128.1 USD -0.11%-1.00%-2.58%5.28%
5.23 USD +1.95%+1.75%+270.92%4.97%
68.04 USD -2.36%-3.15%+81.01%4.29%
49 USD +1.22%+4.72%-42.37%3.83%
333.4 USD -0.02%-3.14%-29.04%3.73%
11.7 USD -2.90%-9.79%+23.94%3.60%
See all (51)
In partnership with
TrackInsight
Date Price Change Volume
24-03-18 18.06 -0.55% 2,422
24-03-15 18.16 +0.32% 1,333
24-03-14 18.1 -2.31% 1,473
24-03-13 18.53 +0.12% 0
24-03-12 18.51 -0.42% 622

Delayed Quote Nyse

Last update March 18, 2024 at 04:10 pm EDT

More quotes

ETF Ratings

Description

US26924G7631
Total Expense Ratio 0.68%
Asset Class
Sector
Size
Currency
Provider
Underlying Prime Treatments, Testing and Advancements GTR Index - USD

Features and characteristics

Jurisdiction
Fund Structure
Replication Method
Replication Model
Date of creation
2020-06-16
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( -0001-11-29 )

AuM 1M 12 M€
AuM 3 months 12 M€
AuM 6 months 15 M€
AuM 12 months 21 M€
  1. Stock
  2. ETF
  3. ETF ETFMG Treatments Testing and Advancements ETF - USD - Nyse